Vaccine against pancreatic cancer, and medical use thereof
AssigneeYuanben (Zhuhai Hengqin) Biotechnology Co., Ltd.
InventorJiong CAI
Life of this patent
Estimating the term…
Abstract
An anti-tumor fusion protein can inhibit the growth of MUC1-positive tumor cells, and can inhibit the growth of pancreatic cancer tumor cells. The fusion protein may contain protein MBP and protein MUC1-N. An amino acid sequence of the fusion protein is set forth in SEO ID NO.3. The fusion protein can be used for the prevention and/or treatment of pancreatic cancer.
Claims10
1-11. (canceled)
A method for preventing and/or treating pancreatic cancer, wherein the method comprises administering to a subject a fusion protein, characterized in the fusion protein comprises protein MBP and protein MUC1-N, and the amino acid sequence of the fusion protein is set forth in SEQ ID NO.3.
A pharmaceutical composition for preventing and/or treating pancreatic cancer, comprising a fusion protein, an aluminum hydroxide adjuvant, and a CpG adjuvant, the amino acid sequence of the fusion protein is set forth in SEQ ID NO.3.
Dependencies are inferred from the claim text.